Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 4,828 $ 2,672
Restricted cash 250
Accounts receivable 5,032 4,672
Other current assets 2,294 1,479
Current assets of discontinued operations 3,093
Total current assets 12,154 12,166
Property and equipment, net 480 317
Other intangible assets, net 861 2,132
Operating lease right of use assets 2,439 1,284
Other long-term assets 45 141
Long-term assets of discontinued operations 22,387
Total assets 15,979 38,427
Current liabilities:    
Accounts payable 1,050 1,374
Accrued salary and bonus 1,456 2,689
Other accrued expenses 8,419 8,462
Line of credit - current 2,500
Current liabilities of discontinued operations 858 3,157
Total current liabilities 14,283 15,682
Contingent consideration 518 1,383
Operating lease liabilities, net of current portion 1,848 520
Line of credit 1,500
Note payable at fair value 11,165 7,942
Other long-term liabilities 4,701 4,577
Long-term liabilities of discontinued operations 2,705
Total liabilities 32,515 34,309
Commitments and contingencies (Note 11)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,367,830 and 4,228,169 shares issued, respectively; 4,296,710 and 4,195,412 shares outstanding, respectively 405 403
Additional paid-in capital 187,516 186,106
Accumulated deficit (249,017) (227,059)
Treasury stock, at cost (71,120 and 32,757 shares, respectively) (1,976) (1,868)
Total stockholders’ deficit (63,072) (42,418)
Total liabilities and stockholders’ deficit (30,557) (8,109)
Total liabilities, preferred stock and stockholders’ deficit $ 15,979 $ 38,427